D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

A meeting between Formula 1 governing body the FIA and engine manufacturers has ended without a clear commitment to any ...